Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Merrick

Showing results (81-90 of 261) with videos related to

Pageof 27
Sort By:
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapyGregor S Merrick, Wayne M Butler, Robert W Galbreath, et al.
American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Urologic Nursing|January 26, 2008
PSA spike after brachytherapy For localized prostate cancerLaurie Abel, Debra Zeroski, Sarah Brammer, et al.
BJU International|March 5, 2003
Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?G S Merrick, W M Butler, R W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Late rectal function after prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urology|October 20, 2004
Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancerGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
The West Virginia Medical Journal|November 22, 2005
Monotherapeutic brachytherapy for clinically organ-confined prostate cancerGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
American Journal of Clinical Oncology|February 13, 2014
Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation TherapyMark Shilkrut, Patrick W McLaughlin, Gregory S Merrick, et al.
The AIDS Reader|May 16, 2000
Clinicians' discussion: trends in HIV careJ Braun, W el-Sadr, S Merrick, et al.
Urology|July 9, 2002
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Pageof 27

Showing results (81-90 of 261) with videos related to

Sort By:
Pageof 27
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapyGregor S Merrick, Wayne M Butler, Robert W Galbreath, et al.
American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Urologic Nursing|January 26, 2008
PSA spike after brachytherapy For localized prostate cancerLaurie Abel, Debra Zeroski, Sarah Brammer, et al.
BJU International|March 5, 2003
Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?G S Merrick, W M Butler, R W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Late rectal function after prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Urology|October 20, 2004
Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancerGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
The West Virginia Medical Journal|November 22, 2005
Monotherapeutic brachytherapy for clinically organ-confined prostate cancerGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
American Journal of Clinical Oncology|February 13, 2014
Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation TherapyMark Shilkrut, Patrick W McLaughlin, Gregory S Merrick, et al.
The AIDS Reader|May 16, 2000
Clinicians' discussion: trends in HIV careJ Braun, W el-Sadr, S Merrick, et al.
Urology|July 9, 2002
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Pageof 27